Balixafortide
Balixafortide (POL6326) is a selective peptidic CXCR4 antagonist with sub-10 nM potency, effectively mobilizing hematopoietic stem/progenitor cells (HSPCs) . It demonstrates anti-cancer potential in research by inhibiting CXCR4-mediated β-arrestin recruitment and calcium signaling, showing >1000-fold selectivity over related receptors like CXCR7 in vitro and in vivo studies.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1864.14
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog